Keys to Success in Direct-to-Patient (DtP) Clinical Trials

In clinical trials, the Direct-to-Patient (DtP) model allows for study medications to be received and administered in a patient’s home rather than a clinical site. The DtP drug supply model has gained momentum in recent years and continues to evolve since it can confer valuable benefits to sponsors and patients.

This white paper:

• Provides a brief overview of factors that drive the rapidly evolving clinical trial design landscape.
• Demonstrates how DtP trials can solve some of the difficulties facing drug sponsors today, including common pitfalls to consider when embarking on a DtP trial.

Read this white paper for key insights into how successful DtP trials can reduce clinical development timelines, reduce trial costs, enhance patient retention, and deliver novel treatments to patients faster.

Request Free!